Curanex Pharmaceuticals Inc Common Stock (CURX) is a Healthcare · Biotechnology company listed on NASDAQ. Price $4.48 (-2.61%), Market cap $0.01B, 52-week low–high $0.27 ~ $9.16.
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Financial statements, price targets, institutional (13F) holdings and related news for Curanex Pharmaceuticals Inc Common Stock are updated in real time on BlackAll Trade.
Curanex Pharmaceuticals Inc Common Stock trades at $4.48 (-2.61%). Real-time quotes and charts are available on BlackAll Trade.
Curanex Pharmaceuticals Inc Common Stock has a market cap of about $0.01B.
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops P